SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough lung cancer
Disease control OngoingThis study tests a new treatment for people with extensive-stage small cell lung cancer who haven't had treatment before. It combines a bispecific antibody (AK104) with chemotherapy and low-dose radiation to see if it's safe and helps control the cancer. About 57 adults aged 18 t…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for tough lung cancer? early trial combines targeted drug with standard care
Disease control OngoingThis early-phase study tests a new drug called RYZ101 added to standard chemotherapy and immunotherapy for people with a specific type of advanced lung cancer (extensive stage small cell lung cancer) that has a certain marker (SSTR+). The main goals are to find the safest dose an…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC